BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 22500370)

  • 1. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results.
    Jauković L; Ilić TV; Dopudja M; Ajdinović B
    Vojnosanit Pregl; 2012 Feb; 69(2):157-62. PubMed ID: 22500370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases.
    Sixel-Döring F; Liepe K; Mollenhauer B; Trautmann E; Trenkwalder C
    J Neurol; 2011 Dec; 258(12):2147-54. PubMed ID: 21547379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.
    Benamer TS; Patterson J; Grosset DG; Booij J; de Bruin K; van Royen E; Speelman JD; Horstink MH; Sips HJ; Dierckx RA; Versijpt J; Decoo D; Van Der Linden C; Hadley DM; Doder M; Lees AJ; Costa DC; Gacinovic S; Oertel WH; Pogarell O; Hoeffken H; Joseph K; Tatsch K; Schwarz J; Ries V
    Mov Disord; 2000 May; 15(3):503-10. PubMed ID: 10830416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
    Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
    J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.
    Lorberboym M; Treves TA; Melamed E; Lampl Y; Hellmann M; Djaldetti R
    Mov Disord; 2006 Apr; 21(4):510-4. PubMed ID: 16250023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of correlative [123I]-FP-CIT brain imaging and neurological findings in suspect Parkinson's disease.
    Covelli EM; Brunetti A; Di Lauro A; Sullo P; Mazzarella G; Tedeschi E; Belfiore G
    Radiol Med; 2004 Oct; 108(4):417-25. PubMed ID: 15525895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FP-CIT and MIBG scintigraphy in early Parkinson's disease.
    Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM
    Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms.
    Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O
    Nucl Med Commun; 2005 May; 26(5):421-6. PubMed ID: 15838424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT.
    Varrone A; Sansone V; Pellecchia MT; Amboni M; Salvatore E; De Michele G; Filla A; Barone P; Pappatà S; Salvatore M
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1343-9. PubMed ID: 18283454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
    J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor.
    Doepp F; Plotkin M; Siegel L; Kivi A; Gruber D; Lobsien E; Kupsch A; Schreiber SJ
    Mov Disord; 2008 Feb; 23(3):405-10. PubMed ID: 18067184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson's disease.
    Kahraman D; Eggers C; Schicha H; Timmermann L; Schmidt M
    J Neurol; 2012 Feb; 259(2):251-60. PubMed ID: 21750954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images.
    Kas A; Payoux P; Habert MO; Malek Z; Cointepas Y; El Fakhri G; Chaumet-Riffaud P; Itti E; Remy P
    J Nucl Med; 2007 Sep; 48(9):1459-67. PubMed ID: 17704252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
    Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
    Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
    Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
    Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
    J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease.
    Brajkovic LD; Svetel MV; Kostic VS; Sobic-Saranovic DP; Pavlovic SV; Artiko VM; Obradovic VB
    Hell J Nucl Med; 2012; 15(2):134-8. PubMed ID: 22833860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 123I-FP-CIT SPECT imaging of the dopaminergic state. Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques.
    Kahraman D; Eggers C; Holstein A; Schneider C; Pedrosa DJ; Dietlein M; Kobe C; Timmermann L; Schmidt M
    Nuklearmedizin; 2012; 51(6):244-51. PubMed ID: 22526237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes.
    Hauser RA; Grosset DG
    J Neuroimaging; 2012 Jul; 22(3):225-30. PubMed ID: 21410815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative evaluation of striatal I-123-FP-CIT uptake in essential tremor and parkinsonism.
    Cuberas-Borrós G; Lorenzo-Bosquet C; Aguadé-Bruix S; Hernández-Vara J; Pifarré-Montaner P; Miquel F; Álvarez-Sabin J; Castell-Conesa J
    Clin Nucl Med; 2011 Nov; 36(11):991-6. PubMed ID: 21975386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.